Healthcare & Life Sciences
Permeon Biologics
United States
dead
About
Permeon Biologics was a biopharmaceutical company that developed intracellular biologics by remodeling protein surfaces to enable cell penetration while preserving structure and activity, targeting previously undruggable proteins using a Harvard-licensed technology platform.
Explore Permeon Biologics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.